|Bid||0.000 x 0|
|Ask||0.000 x 0|
|Day's Range||0.096 - 0.104|
|52 Week Range||0.090 - 0.250|
|PE Ratio (TTM)||-13.00|
|Earnings Date||Nov 7, 2017 - Nov 13, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||4.00|
NORTHVALE, N.J., Sept. 20, 2017-- Elite Pharmaceuticals, Inc. announced that it has filed an Abbreviated New Drug Application with the US Food and Drug Administration for a generic version of OxyContin ...
NORTHVALE, N.J., Aug. 30, 2017-- Elite Pharmaceuticals, Inc. announced today it will present data for ELI-200 at PAINWeek 2017 National Conference held in Las Vegas, Nevada, USA September 4– 8, 2017. The ...
NORTHVALE, N.J., Aug. 09, 2017-- Elite Pharmaceuticals, Inc., a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, announced results for the first quarter of ...